|
Lymphoid Neoplasia
Citations 241-250 of 299 total displayed.
|
Past content
(since Jan 2009):
|
The enzymatic activity of 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase is enhanced by NPM-ALK: new insights in ALK-mediated pathogenesis and the treatment of ALCL
- Francesco E. Boccalatte, Claudia Voena, Chiara Riganti, Amalia Bosia, Lucia D'Amico, Ludovica Riera, Mangeng Cheng, Bruce Ruggeri, Ole N. Jensen, Valerie L. Goss, Kimberly Lee, Julie Nardone, John Rush, Roberto D. Polakiewicz, Michael J. Comb, Roberto Chiarle, and Giorgio Inghirami
Blood 2009; 113: 2776-2790.
[Abstract]
[Full text]
[PDF]
PKCβ is essential for the development of chronic lymphocytic leukemia in the TCL1 transgenic mouse model: validation of PKCβ as a therapeutic target in chronic lymphocytic leukemia
- Claudia Holler, Josefina D. Piñón, Ursula Denk, Christoph Heyder, Sebastian Hofbauer, Richard Greil, and Alexander Egle
Blood 2009; 113: 2791-2794.
[Abstract]
[Full text]
[PDF]
Genome-wide epigenetic analysis delineates a biologically distinct immature acute leukemia with myeloid/T-lymphoid features
- Maria E. Figueroa, Bas J. Wouters, Lucy Skrabanek, Jacob Glass, Yushan Li, Claudia A. J. Erpelinck-Verschueren, Anton W. Langerak, Bob Löwenberg, Melissa Fazzari, John M. Greally, Peter J. M. Valk, Ari Melnick, and Ruud Delwel
Blood 2009; 113: 2795-2804.
[Abstract]
[Full text]
[PDF]
PARP-14, a member of the B aggressive lymphoma family, transduces survival signals in primary B cells
- Sung Hoon Cho, Shreevrat Goenka, Tiina Henttinen, Prathyusha Gudapati, Arja Reinikainen, Christine M. Eischen, Riitta Lahesmaa, and Mark Boothby
Blood 2009; 113: 2416-2425.
[Abstract]
[Full text]
[PDF]
Expression of sprouty2 inhibits B-cell proliferation and is epigenetically silenced in mouse and human B-cell lymphomas
- Matthew J. Frank, David W. Dawson, Steven J. Bensinger, Jason S. Hong, Wendy M. Knosp, Lizhong Xu, Cynthia E. Balatoni, Eric L. Allen, Rhine R. Shen, Dafna Bar-Sagi, Gail R. Martin, and Michael A. Teitell
Blood 2009; 113: 2478-2487.
[Abstract]
[Full text]
[PDF]
New insights into the biology and origin of mature aggressive B-cell lymphomas by combined epigenomic, genomic, and transcriptional profiling
- José I. Martín-Subero, Markus Kreuz, Marina Bibikova, Stefan Bentink, Ole Ammerpohl, Eliza Wickham-Garcia, Maciej Rosolowski, Julia Richter, Lidia Lopez-Serra, Esteban Ballestar, Hilmar Berger, Xabier Agirre, Heinz-Wolfram Bernd, Vincenzo Calvanese, Sergio B. Cogliatti, Hans G. Drexler, Jian-Bing Fan, Mario F. Fraga, Martin L. Hansmann, Michael Hummel, Wolfram Klapper, Bernhard Korn, Ralf Küppers, Roderick A. F. MacLeod, Peter Möller, German Ott, Christiane Pott, Felipe Prosper, Andreas Rosenwald, Carsten Schwaenen, Dirk Schübeler, Marc Seifert, Benjamin Stürzenhofecker, Michael Weber, Swen Wessendorf, Markus Loeffler, Lorenz Trümper, Harald Stein, Rainer Spang, Manel Esteller, David Barker, Dirk Hasenclever, for the Molecular Mechanisms in Malignant Lymphomas Network Project of the Deutsche Krebshilfe, and Reiner Siebert
Blood 2009; 113: 2488-2497.
[Abstract]
[Full text]
[PDF]
Regulation of multiple myeloma survival and progression by CD1d
- Emmanouil Spanoudakis, Ming Hu, Kikkeri Naresh, Evangelos Terpos, Valeria Melo, Alistair Reid, Ioannis Kotsianidis, Saad Abdalla, Amin Rahemtulla, and Anastasios Karadimitris
Blood 2009; 113: 2498-2507.
[Abstract]
[Full text]
[PDF]
Mouse models of non-Hodgkin lymphoma reveal Syk as an important therapeutic target
- Ryan M. Young, Ian R. Hardy, Raedun L. Clarke, Nicolai Lundy, Polly Pine, Brian C. Turner, Terry A. Potter, and Yosef Refaeli
Blood 2009; 113: 2508-2516.
[Abstract]
[Full text]
[PDF]
Ex vivo characterization of polyclonal memory CD8+ T-cell responses to PRAME-specific peptides in patients with acute lymphoblastic leukemia and acute and chronic myeloid leukemia
- Katayoun Rezvani, Agnes S. M. Yong, Abdul Tawab, Behnam Jafarpour, Rhoda Eniafe, Stephan Mielke, Bipin N. Savani, Keyvan Keyvanfar, Yixin Li, Roger Kurlander, and A. John Barrett
Blood 2009; 113: 2245-2255.
[Abstract]
[Full text]
[PDF]
Expression of the oncofetal ED-B–containing fibronectin isoform in hematologic tumors enables ED-B–targeted 131I-L19SIP radioimmunotherapy in Hodgkin lymphoma patients
- Stefanie Sauer, Paola A. Erba, Mario Petrini, Andreas Menrad, Leonardo Giovannoni, Chiara Grana, Burkhard Hirsch, Luciano Zardi, Giovanni Paganelli, Giuliano Mariani, Dario Neri, Horst Dürkop, and Hans D. Menssen
Blood 2009; 113: 2265-2274.
[Abstract]
[Full text]
[PDF]
|
|
